Abstract:Studies on gene expression in response to therapy have led to the discovery of pharmacogenomics biomarkers and advances in precision medicine. Whole transcriptome sequencing (RNA-seq) is an emerging tool for profiling gene expression and has received wide adoption in the biomedical research community. However, its value in regulatory decision making requires rigorous assessment and consensus between various stakeholders, including the research community, regulatory agencies, and industry. The FDA-led SEquencing Quality Control (SEQC) consortium has made considerable progress in this direction, and is the subject of this review. Specifically, three RNA-seq platforms (Illumina HiSeq, Life Technologies SOLiD, and Roche 454) were extensively evaluated at multiple sites to assess cross-site and cross-platform reproducibility. The results demonstrated that relative gene expression measurements were consistently comparable across labs and platforms, but not so for the measurement of absolute expression levels. As part of the quality evaluation several studies were included to evaluate the utility of RNA-seq in clinical settings and safety assessment. The neuroblastoma study profiled tumor samples from 498 pediatric neuroblastoma patients by both microarray and RNA-seq. RNA-seq offers more utilities than microarray in determining the transcriptomic characteristics of cancer. However, RNA-seq and microarray-based models were comparable in clinical endpoint prediction, even when including additional features unique to RNA-seq beyond gene expression. The toxicogenomics study compared microarray and RNA-seq profiles of the liver samples from rats exposed to 27 different chemicals representing multiple toxicity modes of action. Cross-platform concordance was dependent on chemical treatment and transcript abundance. Though both RNA-seq and microarray are suitable for developing gene expression based predictive models with comparable prediction performance, RNA-seq offers advantages over microarray in profiling genes with low expression. The rat BodyMap study provided a comprehensive rat transcriptomic body map by performing RNA-Seq on 320 samples from 11 organs in either sex of juvenile, adolescent, adult and aged Fischer 344 rats. Lastly, the transferability study demonstrated that signature genes of predictive models are reciprocally transferable between microarray and RNA-seq data for model development using a comprehensive approach with two large clinical data sets. This result suggests continued usefulness of legacy microarray data in the coming RNA-seq era. In conclusion, the SEQC project enhances our understanding of RNA-seq and provides valuable guidelines for RNA-seq based clinical application and safety evaluation to advance precision medicine.

Significant Improvement in Data Quality with Simplified SCRB-seq.

Exploring Additional Valuable Information from Single-Cell RNA-Seq Data.

A Review of Single-Cell RNA-Seq Annotation, Integration, and Cell-Cell Communication

Prudent Application of Single-Cell RNA Sequencing in Understanding Cellular Features and Functional Phenotypes in Cancer Studies

Single-Cell Sequencing Methodologies: From Transcriptome To Multi-Dimensional Measurement

Toward uncharted territory of cellular heterogeneity: advances and applications of single-cell RNA-seq

ctQC improves biological inferences from single cell and spatial transcriptomics data

Single-Cell RNA-Seq Technologies and Related Computational Data Analysis.

Single‐cell RNA sequencing technologies and applications: A brief overview

Identifying Cell Types To Interpret Scrna-Seq Data: How, Why And More Possibilities

The Advancement and Application of the Single-Cell Transcriptome in Biological and Medical Research

Precision and Accuracy of Single-Cell/Nuclei RNA Sequencing Data

Recent progress in single-cell RNA-Seq analysis]

Single cell RNA‐sequencing: A powerful yet still challenging technology to study cellular heterogeneity

BCseq: accurate single cell RNA-seq quantification with bias correction

Comprehensive Assessments of RNA-seq by the SEQC Consortium: FDA-Led Efforts Advance Precision Medicine

Scqa: A Dual-Perspective Cell Type Identification Model for Single Cell Transcriptome Data

Advanced sequencing-based high-throughput and long-read single-cell transcriptome analysis.

Automated high-throughput profiling of single-cell total transcriptome with scComplete-seq

A Strategy to Compare Single-Cell RNA Sequencing Data Sets Provides Phenotypic Insight into Cellular Heterogeneity Underlying Biological Similarities and Differences Between Samples

Data analysis guidelines for single-cell RNA-seq in biomedical studies and clinical applications